Journal Basic Info
- Neoadjuvant Therapy
- Melanoma/Skin Cancer
- Bladder Cancer
- Prostate Cancer
- Pancreatic Cancer
- Radiation Oncology
- Paediatric Cancers
Citation: Clin Oncol. 2021;6(1):1768.DOI: 10.25107/2474-1663.1768
Thomas Mulliez, Thierry Gevaert, Kurt Barbé and Mark de Ridder
Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Belgium
Department of Radiotherapy, Institut Andrée Dutreix, France
Department of Public Health, Vrije Universiteit Brussel, Belgium
Aims: Breast cancer patients receiving radiotherapy have an excellent oncological prognosis. However, these patients are at risk for long-term cardiovascular iatrogenic events and currently no individualized cardiovascular screening and prevention is routinely performed.
Methods and Results: By integrating data of the SCORE risk charts and radiotherapy excess ratios, we were able to develop 10-year cardiovascular mortality risk charts based on mean heart dose, age, systolic blood pressure, smoking-status and cholesterol for high- and low-risk regions in Europe.
Conclusion: Breast cancer patients are long-term survivors and individualization of breast radiotherapy and cardiovascular screening and prevention is warranted, not only based on cardiovascular risk factors but also heart dose.
Breast cancer; Radiotherapy; Cardiovascular mortality
Cite the Article:
Mulliez T, Gevaert T, Barbé K, de Ridder M. Cardiovascular Screening and Prevention in Female Breast Cancer Patients Receiving Radiotherapy. Clin Oncol. 2021;6:1768..